Metformin Market

Metformin Market Size, Share & Industry Analysis, By Source:-(Pharmaceutical Manufacturers (Branded & Generic), Contract Manufacturing Organizations (CMOs), Research-Grade Suppliers.) By End-User:-(Pharmaceutical Industry, Hospitals & Clinics, Research Institutions) and Forecast, 2025-2035

The Metformin market is projected to grow at a CAGR of 5.3% from 2025 to 2035, fueled by the rising global burden of type 2 diabetes, prediabetes, and polycystic ovary syndrome (PCOS). Metformin is a first-line oral antihyperglycemic agent that improves insulin sensitivity, decreases hepatic glucose production, and enhances peripheral glucose uptake without causing significant hypoglycemia or weight gain. It is also being investigated for its potential benefits in cancer prevention, aging, and cardiovascular health.

The market is driven by increasing diabetes incidence linked to sedentary lifestyles, obesity, and aging populations, particularly in developing regions. The widespread use of metformin as a foundational therapy in both monotherapy and combination regimens ensures its continual demand. Additionally, the growing availability of extended-release (XR) formulations and fixed-dose combinations (FDCs) with DPP-4 inhibitors, SGLT2 inhibitors, and insulin enhances patient compliance and therapeutic flexibility.

Regionally, Asia-Pacific dominates the Metformin market due to the sheer volume of diabetic patients in countries like India and China. Government-led programs, generic drug manufacturing, and increasing access to primary healthcare support growth. North America follows closely due to high healthcare spending, ongoing research into metformin’s secondary indications, and strong adoption of combination therapies. Europe also holds a significant share, especially with long-established treatment guidelines incorporating metformin.

Seeking Comprehensive Intelligence on Different markets? Get in Touch with our Experts

Report Scope & Segmentation

Introduction

Overview of Metformin
Key Applications & Industry Use Cases
Market Scope & Study Objectives

Market Overview

Global Market Size & Growth Trends (Historical & Forecast)
Market Value & Revenue Analysis
Demand-Supply Dynamics

Segmental Outlook

By Source
- Pharmaceutical Manufacturers (Branded & Generic)
- Contract Manufacturing Organizations (CMOs)
- Research-Grade Suppliers
Key End-Use Industries
- Pharmaceutical Industry.
- Hospitals & Clinics.
- Research Institutions.

Price Analysis

Current Price Trends (Per kg & Per Ton)
Price Fluctuation Factors (Raw Material Costs, Production, Trade Tariffs)
Regional Price Comparison (North America, Europe, Asia-Pacific, and Other)

Production & Supply Volume

Global Production Capacity & Key Manufacturers
Production Process & Technological Developments
Raw Material Analysis

Trade Analysis (Import & Export)

Major Exporting & Importing Countries
Trade Volume & Value Statistics
Impact of Trade Regulations & Policies

Regional Analysis

North America (US and Canada)
Europe (UK, Germany, France, Italy, Spain, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, Taiwan, India, and Rest of Asia-Pacific)
Rest of the World (Latin America, Middle East, and Africa)

Competitive Landscape

Top Global Manufacturers & Market Share
Company Profiles & Key Developments
Mergers, Acquisitions & Investments

Regulatory & Compliance Factors

FDA, REACH, and Other Regulatory Frameworks
Environmental & Safety Considerations
Emerging Policies Impacting Market Growth

Conclusion & Strategic Recommendations

Key Takeaways for Stakeholders
Market Entry Strategies

May 14, 2025

What is Metformin?

Metformin is a biguanide-class oral antihyperglycemic drug widely used as the first-line treatment for type 2 diabetes mellitus (T2DM). It works primarily by reducing hepatic glucose production (gluconeogenesis), improving insulin sensitivity, and enhancing peripheral glucose uptake. Metformin does not cause hypoglycemia when used alone and is also being investigated for benefits in polycystic ovary syndrome (PCOS), prediabetes, anti-aging, and cancer prevention. It is available in immediate-release and extended-release formulations.

What is the market growth of Metformin?

The global Metformin market is projected to grow at a CAGR of 4.5% from 2025 to 2035, increasing from USD 4.9 billion in 2025 to around USD 7.6 billion by 2035. This growth is driven by the global diabetes epidemic, increasing use of combination therapies, and expansion into non-diabetic indications like metabolic syndrome and PCOS.

What are the drivers of the Metformin market?

Key drivers include the increasing global prevalence of T2DM, strong clinical endorsement in treatment guidelines, and its cost-effectiveness and safety profile. Demand is further fueled by expanding healthcare access in developing nations, rising obesity rates, and the drug’s emerging role in longevity research and oncology. Metformin’s generic availability ensures affordability and broad usage across income groups.

Who are the key players operating in the Metformin market?

Leading players include Merck KGaA, Teva Pharmaceuticals, Sun Pharmaceutical Industries, Mylan (Viatris), Bristol Myers Squibb (Glucophage originator), Torrent Pharmaceuticals, and Aurobindo Pharma. Both standalone and fixed-dose combination (FDC) products with agents like sitagliptin, dapagliflozin, or glimepiride are widely marketed.

Which region will exhibit the fastest growth in the Metformin market?

Asia-Pacific is expected to witness the fastest growth due to the high and rising diabetic population, especially in India and China, as well as government initiatives to expand affordable diabetes care. North America continues to lead in revenue due to well-established healthcare infrastructure, combination therapy adoption, and increased off-label research interest, while Europe maintains steady growth driven by universal healthcare access and aging demographics.

$1800/- Single User License
$3600/- Multi User License

Experienced in market research and consulting.
Seasoned professionals with diverse industry knowledge.
Proven track record in delivering valuable insights.
Tailored methodologies for unique client needs.
End-to-end services: market analysis, competitor intelligence, consumer behavior, and strategic recommendations.
Latest tools and tech for data collection, analysis, and visualization.
Embrace of AI and machine learning for deeper insights.
Global capabilities and extensive network.
In-depth understanding of international markets, trends, and regulations.
Dedicated to addressing specific client needs and goals.
Focus on delivering value through efficient research outcomes.

How can we help you?

Reach out to discuss how our team can help your business achieve real results.

Contact Person

Mr. Anurag Tiwari

Call Us

+91-780-304-0404

Mail Us

info@omrglobal.com